90
Participants
Start Date
May 12, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
simufilam
simufilam 100 mg oral tablet, twice daily
IMIC Research, Palmetto Bay
Brain Matters Research, Delray Beach
Neuropsychiatric Research Center of Southwest Florida, Fort Myers
the Ohio State University, Columbus
Cognitive Clinical Trials, Papillion
Senior Adults Specialty Research, Austin
Cognitive Clinical Trials, Gilbert
Valley Research Center, Inc., Imperial
Advanced Memory Research Institute of NJ, Toms River
Recherches Neuro-Hippocampe Inc., d/b/a Ottawa Memory Clinic, Ottawa
Toronto Memory Program ULC, Toronto
Lead Sponsor
Cassava Sciences, Inc.
INDUSTRY